The objectives of the present study were to analyze our hospital’s clinical management of EGFR-mutated NSCLC patients, with a specific emphasis on how we used LB techniques, and assess the impact of LB techniques on tumor evolution and OS among patients. Here, EGFR is linked to non-small cell lung carcinoma.